Related Experiment Videos
Tumour necrosis factor and polymorphonuclear leukocytes in alcoholic hepatitis
Alcohol and Alcoholism (Oxford, Oxfordshire)
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antiphospholipid syndrome with complete abdominal aorta occlusion and chondritis.
Modern rheumatology·2014
Rapidly progressive glomerulonephritis with D-penicillamine.
The American journal of the medical sciences·2001
Progressive appearance of overlap syndrome together with autoantibodies in a patient with fatal thrombotic microangiopathy.
The American journal of the medical sciences·2000
Changes in clinical features and long-term prognosis in patients with pheochromocytoma.
American journal of hypertension·2000
Linking five-factor personality model to alcohol consumption in adolescence: a systematic review and meta-analysis.
Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Examining alcohol use disorder recovery definitions and demographic reporting in studies of structural brain recovery: an updated systematic review and extension.
Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Six approved drugs for alcohol use disorder: algorithms for their use according to the aims of treatment.
Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Clinical mental health diagnoses among anabolic-androgenic steroid consumers classified as low-risk or hazardous drinkers: a brief report.
Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Day-to-day links between negative affect, distress intolerance, and alcohol use.
Alcohol and alcoholism (Oxford, Oxfordshire)·2026
HEPARIN-INDUCED THROMBOCYTOPENIA AND ITS IMPACT ON INPATIENT OUTCOMES IN INFLAMMATORY BOWEL DISEASE.
The American journal of the medical sciences·2026
PCBP1 joins the regulatory network of the endothelial-to-hematopoietic transition.
Experimental hematology·2026
Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results.
Clinical and translational allergy·2026